Get the Stockscreener App
2.17
8.44%
-0.20
Pre-market:
1.61
-0.56
-25.81%
Rein Therapeutics Inc stock is traded at $2.17, with a volume of 52,721.
It is down -8.44% in the last 24 hours and down -1.36% over the past month.
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.
See More
Previous Close:
$2.37
Open:
$2.4
24h Volume:
52,721
Relative Volume:
1.34
Market Cap:
$47.02M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-7.66%
1M Performance:
-1.36%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.16
$2.42
1-Week Range:
$2.16
$2.96
52-Week Range:
$1.8396
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
Name
Rein Therapeutics Inc
Sector
Industry
Phone
(737) 802-1989
Address
12407 N. MOPAC EXPY., AUSTIN
Compare RNTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
2.17 | 47.02M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
480.35 | 123.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
723.47 | 79.09B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.94 | 37.97B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.20 | 31.74B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
259.70 | 27.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-24-17 | Initiated | BofA/Merrill | Buy |
| Jul-24-17 | Initiated | Jefferies | Buy |
| Jul-24-17 | Initiated | William Blair | Outperform |
Rein Therapeutics Inc Stock (RNTX) Latest News
Should You Invest in Wolfspeed Inc (WOLF) Now? - The News Heater
Esco Technologies, Inc (ESE) Shares Up Despite Recent Market Volatility - The News Heater
PDD Holdings Inc ADR (PDD) Shares Rise Despite Market Challenges - The News Heater
Palantir Technologies Inc (PLTR) Stock: A Closer Look at the Analyst Ratings - The News Heater
Rein Therapeutics (RNTX) Income Statement & Balance Sheet 2025 - MarketBeat
Smart brands rein in ad spending when a rival faces a setback − here’s why - Yahoo Finance
Zimbabwe Plans New Measures to Rein In Proliferating Informal Sector - Yahoo Finance
United Therapeutics president sells shares worth $3.7 million - MSN
Rodman & Renshaw sets $8 target for Rein Therapeutics stock By Investing.com - Investing.com Canada
Analysis-Trump's digital dollar ban gives China and Europe's CBDCs free rein - Yahoo Finance
Rodman & Renshaw sets $8 target for Rein Therapeutics stock - Investing.com India
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Stock market news: Blackboxstocks +105.33%, ScanTech AI Systems +59.14% among top gainers during mid day trading - Business Upturn
Aileron Therapeutics, Inc. announced that it has received $42 million in funding from a group of investors. - Marketscreener.com
Atara stock extends losses on FDA clinical hold (ATRA:NASDAQ) - Seeking Alpha
GeneTether Therapeutics Rebrands as Rize Oncology, Focuses on Cancer Treatment - MSN
Old Lyme horse riding center gives Parkinson's patients the reins - theday.com
Free Rein Coffee Company® Expands Distribution of Free Rein Reserve™ Collection - Yahoo Canada Finance
Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma - Marketscreener.com
Aileron Therapeutics, Inc. Announces Board Changes - Marketscreener.com
Aileron Therapeutics, Inc. Announces Board Changes -April 01, 2019 at 06:16 am EDT - Marketscreener.com
Aileron Therapeutics to be Included in the Russell Microcap® Index - Marketscreener.com
Aileron Therapeutics Announces Appointments to Scientific Advisory Board -March 28, 2018 at 07:00 am EDT - Marketscreener.com
Aileron Therapeutics Announces the Promotion of Richard J. Wanstall to Chief Financial Officer and Treasurer - Marketscreener.com
Aileron Therapeutics Announces Board Appointments -June 24, 2019 at 08:00 am EDT - Marketscreener.com
Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - Marketscreener.com
Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights - Marketscreener.com
Aileron Therapeutics, Inc. Announces Management Changes - Marketscreener.com
Aileron Therapeutics Announces Management Changes - Marketscreener.com
Aileron Therapeutics, Inc. Announces CEO Changes -March 12, 2024 at 08:00 am EDT - Marketscreener.com
Aileron Therapeutics Announces Management Changes -September 06, 2018 at 09:10 am EDT - Marketscreener.com
Rein Therapeutics announces name change and new ticker By Investing.com - Investing.com South Africa
Rein Therapeutics announces name change and new ticker - Investing.com
Aileron Therapeutics announces rebranding to Rein Therapeutics - MSN
Aileron Therapeutics Announces Rebranding to Rein Therapeutics - PR Newswire
Rein Therapeutics Rebrands And Focuses On Pulmonary And Fibrosis Therapies - Nasdaq
Warren Stephens steps down, turns reins of Stephens, Inc. over to his sons - KARK
New law set to rein in drug costs for many in Mass. - GazetteNET
Achilles Therapeutics sells technology assets to AstraZeneca - Seeking Alpha
Steps to rein in pharmacy benefit managers in US bill "manageable" for firms - Reuters
Tonix stock jumps on FDA review for pain drug (TNXP:NASDAQ) - Seeking Alpha
Reins of Life in South Bend rides ahead with major expansion - WSBT-TV
Empyrean Technology gives control to CEC after U.S. blacklisting — China’s top developer of chip design systems hands reins to state-owned firm - Yahoo Finance
Saudi Arabia to rein in spending next year - Yahoo! Voices
Landmark Lawsuit Challenges SEC Authority by State AGs and Crypto Advocates - Yahoo Finance
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs - Yahoo Finance
Cogent Biosciences to Present Key Bezuclastinib Trial Data at ASH 2024 Meeting - StockTitan
Starbucks needs you to rein in highly customized drink orders — ‘We have some cleanup to do,’ CEO Brian Niccol says - Yahoo Finance
Chester County nonprofit provides therapeutic services while on horseback - 6ABC Philadelphia
Spero to cut 39% of workforce on failed study, stock plunges 20% (NASDAQ:SPRO) - Seeking Alpha
Rein Therapeutics Inc Stock (RNTX) Financials Data
There is no financial data for Rein Therapeutics Inc (RNTX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):